Jubilant Ingrevia's Stock Sees 6.51% Increase, Outperforms Sector and Sensex

Jubilant Ingrevia, a midcap pharmaceutical company, saw a 6.51% increase in its stock price on April 10th, 2024. This rise in stock price was accompanied by a 'Hold' call from MarketsMOJO, a leading financial analysis platform.

The stock hit a new 52-week high of Rs. 528 on the same day, outperforming the sector by 7.81%. It also showed a consecutive gain for the last two days, with a 8.24% return in that period. The intraday high for the stock was Rs. 528, a 7.52% increase from the previous day.

Jubilant Ingrevia's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.

In comparison to the Sensex, Jubilant Ingrevia's stock performance has been significantly higher, with a 1-day performance of 7.52% compared to Sensex's 0.29% and a 1-month performance of 11.50% compared to Sensex's 1.06%.

Jubilant Ingrevia's stock has shown strong growth and positive performance in the recent days, making it a company to watch in the midcap pharmaceutical industry. Investors should keep an eye on the company's future developments and performance.